Biocon Acquisition Worth ₹5.48 Cr

Biocon Board Meeting Date

Biocon schedules a November 4, 2026 board meeting for Q2 FY27 unaudited results, plus an earnings call. Trading window stays closed until November 6, 2026.

Biocon Business Update

Biocon signed a licence agreement with Janssen to commercialise biosimilar Yesintek in nine more markets, including Australia, Brazil and China. No deal value is disclosed.

Biocon Other Announcement

Biocon Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing details the distribution of equity shares among various stakeholder categories.

Biocon Partnership

Biocon entered a global patent settlement and license agreement with Genentech, securing early launch dates for its biosimilar Pebrilzo® (bPertuzumab) across key global markets.

From

Genentech

Biocon Legal & Regulatory

Biocon received a GST demand order for ₹3.21 Crore, including tax, interest, and penalty. The company intends to file a rectification application or appeal.

Value

₹3.21 Cr

Biocon Employee Stock Options

Biocon Limited announced the grant of 94,60,232 stock options to eligible employees under its Biocon Unity Long Term Incentive Plan 2026.

Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr

KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.

Value

₹15.00 Cr

Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr

KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.

Value

₹79.50 Cr

Meesho Acquisition Worth ₹50 Cr

Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.

Value

₹50.00 Cr

Execution

Within 1 year from the closing of the first tranche of the original acquisition

Meesho Acquisition Worth ₹18.74 Cr

Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.

Value

₹18.74 Cr

Meesho Acquisition Worth ₹6.17 Cr

Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.

Value

₹6.17 Cr

Skyways Air Services Acquisition Worth ₹3.13 Cr

Skyways Air Services will invest Rs.3.13 Crore in cash for additional equity in UAE subsidiary Skyways SLS Cargo Services LLC. The investment funds working capital needs.

Value

₹3.13 Cr

Execution

Indicative completion within 30 days